What is the risk of magnesium toxicity in an adult with impaired renal function or other medical conditions after taking a 30ml dose of milk of magnesia (magnesium hydroxide)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk of Magnesium Toxicity from 30ml Milk of Magnesia in Adults with Impaired Renal Function

A single 30ml dose of milk of magnesia poses significant risk of life-threatening hypermagnesemia in patients with impaired renal function, particularly those with creatinine clearance <20 mL/min or end-stage renal disease, and should be absolutely avoided in these populations. 1, 2

Understanding the Risk in Renal Impairment

The kidneys are responsible for nearly all magnesium excretion from the body, and patients with chronic kidney disease have limited ability to excrete magnesium loads, even though compensatory mechanisms reduce tubular reabsorption to maintain adequate urinary excretion until very advanced disease 3. However, in end-stage renal disease, this compensatory mechanism fails, and even modest magnesium intake can result in toxic serum concentrations 3.

Magnesium supplementation is absolutely contraindicated when creatinine clearance falls below 20 mL/min due to the risk of life-threatening hypermagnesemia 2. The use of magnesium-based preparations in patients with chronic kidney disease should be avoided because of possible magnesium toxicity 1.

Clinical Manifestations of Toxicity

Severe hypermagnesemia from milk of magnesia can manifest with:

  • Cardiac effects: Severe bradycardia, asystole, atrial fibrillation with QRS widening, diffuse ST elevation mimicking acute coronary syndrome, and hypotension 4
  • Neurological effects: Loss of consciousness, confusion, hypothermia, and respiratory failure requiring intubation 4, 5
  • ECG changes: Prolonged PR, QRS and QT intervals at levels of 2.5-5 mmol/L, progressing to AV nodal conduction block and cardiac arrest at levels of 6-10 mmol/L 1

The clinical presentation can mimic ST-elevation myocardial infarction, cardiogenic shock, or septic shock, making diagnosis challenging 4.

Case Evidence of Toxicity

A documented case involved a male patient with end-stage renal disease who developed severe bradycardia and asystole after using milk of magnesia, with serum magnesium >4.1 mmol/L (>10 mg/dL) 4. Another fatal case occurred in a 42-year-old woman with normal renal function but bowel obstruction who received 30ml milk of magnesia nightly plus Maalox 30ml three times daily, resulting in serum magnesium of 9.1 mEq/L and ultimately fatal cardiac arrest 5.

Risk Factors Beyond Renal Dysfunction

Even patients with normal renal function are at increased risk when:

  • Bowel obstruction or decreased gastrointestinal motility is present, as this increases magnesium absorption time and total absorption 5
  • Oliguria develops, particularly in pregnant women receiving magnesium sulfate for preeclampsia 1
  • Metabolic derangements coexist, which can cause toxicity after relatively lower magnesium doses 1

People using magnesium-containing medications for relief of gastrointestinal distress may be at increased risk for hypermagnesemia, as the underlying condition may impair normal elimination 5.

Absorption Considerations

While magnesium from oral magnesium sulfate is absorbed to a limited extent in healthy adults (only 4-7% of a cathartic dose is excreted in urine over 72 hours) 6, this limited absorption becomes clinically significant when excretion is impaired 6. The variability in absorption (ranging from 2.9% to 7.0% between individuals) means some patients absorb substantially more than others 6.

Clinical Algorithm for Risk Assessment

Step 1: Assess Renal Function

  • Check creatinine clearance before any magnesium-containing product
  • If CrCl <20 mL/min: Absolute contraindication - do not give 2
  • If CrCl 20-30 mL/min: Avoid unless life-threatening emergency 2
  • If CrCl 30-60 mL/min: Use extreme caution with reduced doses and close monitoring 2

Step 2: Identify Additional Risk Factors

  • Bowel obstruction or ileus 5
  • Oliguria or acute kidney injury 1
  • Concurrent use of other medications affecting renal function 5
  • Advanced age or metabolic derangements 1

Step 3: Consider Safer Alternatives

  • PEG-based laxatives are preferred in patients with any degree of renal insufficiency 1
  • Avoid all magnesium-containing antacids and laxatives in at-risk populations 1, 2

Emergency Management if Toxicity Occurs

If hypermagnesemia develops:

  • Immediate hemodialysis is highly effective and lifesaving for severe toxicity 4
  • Empirical calcium administration may be lifesaving in acute presentations 1
  • Supportive care includes intravenous fluids and furosemide in patients with adequate renal function 5
  • Cardiac monitoring is essential as rhythm can degenerate into fatal pulseless electrical activity 5

Critical Pitfalls to Avoid

  • Never assume a single dose is safe in renal impairment - even 30ml can be fatal 4, 5
  • Don't rely on serum magnesium alone for diagnosis - toxicity can develop rapidly and clinical presentation may precede laboratory confirmation 4
  • Avoid mistaking hypermagnesemia for acute coronary syndrome - severe widening of QRS and ST elevation can mimic STEMI 4
  • Don't overlook bowel obstruction as a risk factor - this dramatically increases absorption even with normal renal function 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Magnesium Supplementation Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Magnesium metabolism in chronic renal failure.

Magnesium research, 1990

Research

Near death by milk of magnesia.

BMJ case reports, 2017

Research

Absorption of magnesium from orally administered magnesium sulfate in man.

Journal of toxicology. Clinical toxicology, 1987

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.